Endocrine Abstracts

Approximately 1% of the population are on some form of long-term glucocorticoid therapy, either as an immunosuppressant or as replacement therapy for adrenal suppression. In recent years, it has become increasingly evident that many of these patients (even those on inhaled steroids) develop adverse consequences of this therapy with the development of iatrogenic Cushing’s syndrome (and its adverse metabolic profile) and associated tertiary adrenal insufficiency due to hypo...

Abstract Unavailable...